| Primary |
| Drug Use For Unknown Indication |
40.0% |
| Fungal Infection |
26.7% |
| Hypertension |
6.7% |
| Pyrexia |
6.7% |
| Restlessness |
6.7% |
| Stress Ulcer |
6.7% |
| Vitamin B1 Deficiency |
6.7% |
|
| Jaundice |
50.0% |
| Liver Disorder |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
37.8% |
| Pneumonia |
15.4% |
| Acute Myeloid Leukaemia |
6.4% |
| Prophylaxis |
5.2% |
| Immunosuppressant Drug Therapy |
3.5% |
| Antifungal Prophylaxis |
3.3% |
| Febrile Neutropenia |
3.3% |
| Peripheral T-cell Lymphoma Unspecified |
2.9% |
| Gastroenteritis Salmonella |
2.5% |
| Pyrexia |
2.5% |
| Infection |
2.1% |
| Pneumonia Bacterial |
2.1% |
| Post Procedural Infection |
2.1% |
| Metastatic Gastric Cancer |
1.9% |
| Fungal Infection |
1.7% |
| Non-hodgkin's Lymphoma |
1.7% |
| Meningitis |
1.5% |
| Neuroleptic Malignant Syndrome |
1.5% |
| Neutrophil Count Decreased |
1.5% |
| Product Used For Unknown Indication |
1.5% |
|
| Sepsis |
10.9% |
| Renal Failure |
9.4% |
| White Blood Cell Count Decreased |
9.4% |
| Interstitial Lung Disease |
7.8% |
| Thrombocytopenia |
7.8% |
| Staphylococcal Infection |
6.3% |
| Transient Ischaemic Attack |
6.3% |
| Liver Disorder |
4.7% |
| Pyrexia |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| Drug Eruption |
3.1% |
| Hypoproteinaemia |
3.1% |
| Meningitis |
3.1% |
| Renal Impairment |
3.1% |
| Respiratory Failure |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Vanishing Bile Duct Syndrome |
3.1% |
| Vomiting |
3.1% |
| Anaphylactoid Reaction |
1.6% |
| Haemoptysis |
1.6% |
|
| Concomitant |
| Prophylaxis |
14.3% |
| Product Used For Unknown Indication |
13.3% |
| Infection Prophylaxis |
9.3% |
| Infection |
7.0% |
| Bone Marrow Conditioning Regimen |
6.8% |
| Sedation |
5.4% |
| Fluid Replacement |
5.3% |
| Prophylaxis Against Graft Versus Host Disease |
4.9% |
| Ureteral Stent Insertion |
4.0% |
| Ureteral Stent Removal |
4.0% |
| Acute Myeloid Leukaemia |
3.5% |
| Blood Bilirubin Increased |
3.4% |
| Pneumonia |
3.4% |
| Pyrexia |
2.9% |
| Diuretic Therapy |
2.5% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Premedication |
2.1% |
| Hypertension |
1.9% |
| Anticoagulant Therapy |
1.9% |
| Insomnia |
1.9% |
|
| Respiratory Failure |
9.8% |
| White Blood Cell Count Increased |
9.2% |
| Thrombocytopenia |
7.8% |
| Septic Shock |
7.2% |
| Thrombotic Microangiopathy |
6.5% |
| Venoocclusive Liver Disease |
6.5% |
| Pneumonia |
5.2% |
| Sepsis |
5.2% |
| Multi-organ Failure |
4.6% |
| Stomatitis |
4.6% |
| Cytomegalovirus Viraemia |
3.9% |
| Febrile Neutropenia |
3.9% |
| Graft Versus Host Disease In Skin |
3.9% |
| Renal Tubular Disorder |
3.9% |
| Shock Haemorrhagic |
3.9% |
| White Blood Cell Count Decreased |
3.3% |
| Depressed Level Of Consciousness |
2.6% |
| Interstitial Lung Disease |
2.6% |
| Renal Failure Acute |
2.6% |
| Shock |
2.6% |
|
